<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"Chinese":1,
"anxiety":1,
"pre-surgery":1,
"thyroid cancer":33,
"thyroid tumor":1,
"Biocontamination":1,
"Endocrine disruptors":1,
"Heavy metals":1,
"Trace elements":1,
"Volcanic environment":1,
"BDNF":1,
"breast cancer":4,
"in vitro cancer assay":1,
"in vivo tumorigenicity":1,
"miR-107":2,
"qRT-PCR":1,
"NSQIP":1,
"cancer":6,
"morbidity":2,
"oncology":2,
"outcome":1,
"resident":1,
"surgery":2,
"lymphoma":1,
"myeloid leukemias":1,
"radiotherapy":2,
"Bisphenol A":1,
"Nuclear receptors":1,
"Pancreatic cancer":1,
"Prostate cancer":1,
"Stress/NF-kB pathway":1,
"biomarkers":1,
"head and neck endocrine pathology":1,
"head and neck endocrine surgery":1,
"surgical outcome":1,
"Papillary thyroid carcinoma":11,
"diagnostic accuracy":1,
"false positivity":1,
"fine-needle aspiration cytology":1,
"intra-operative frozen section":1,
"extrathyroidal extension":2,
"frozen section":1,
"intra-operative":1,
"Glycoprotein":1,
"Invasion":6,
"Prognosis":6,
"Autonomously functioning thyroid nodule":1,
"Elastography":1,
"Scintigraphy":1,
"Ultrasonography":4,
"Adolescence":1,
"Carcinoma, papillary":2,
"Childhood":1,
"Follow-up studies":1,
"Incidence":3,
"Pediatric":1,
"Thyroglossal duct&nbsp":1,
"cyst":2,
"Thyroid neoplasms":11,
"Thyroidectomy":8,
"Cancer stem cells":1,
"Deiodinases":1,
"Thyroid hormone":1,
"Combined small cell carcinoma":1,
"Epithelial-to-mesenchymal transition":1,
"Giant cell carcinoma":1,
"CTLA-4":1,
"Hypophysitis":1,
"Ipilimumab":1,
"Melanoma":1,
"Radioactive iodine":3,
"acoustic rhinometer":1,
"nasal function":1,
"visual analogue scale":1,
"MIGRATION":3,
"PROLIFERATION":7,
"PTC":1,
"PTCSC3":1,
"Wnt/β-CATENIN":1,
"miR-574-5p":1,
"Endoscopic":2,
"Thyroid":11,
"Transoral":1,
"Transoral thyroidectomy":1,
"Focussed ultrasound":1,
"nodule shrinkage":1,
"thermal ablation":6,
"thyroid nodule":9,
"Radiofrequency/microwave":2,
"benign thyroid nodule":5,
"ultrasound":9,
"Focused ultrasound":3,
"hypothyroidism":1,
"thyroid dysfunction":1,
"recurrent laryngeal nerve":1,
"vocal cord palsy":1,
"AEROBIC GLYCOLYSIS":1,
"APOPTOSIS":2,
"COLORECTAL CANCER":3,
"GENE SILENCING":1,
"PKM2":4,
"ANGIOGENESIS":1,
"FGF2":1,
"MALAT1":1,
"TUMOR-ASSOCIATED MACROPHAGES":1,
"thyroid neoplasm":1,
"Radiofrequency ablation":3,
"complication":1,
"recurrent thyroid cancer":1,
"Endoscopic thyroidectomy":2,
"Flap area":1,
"Non-unvisual dissection":1,
"Operating space":1,
"Surgery technique":1,
"Surgical time":1,
"CYP24A1":1,
"CYP27B1":1,
"Histology":1,
"Immunohistochemistry":4,
"Non-genomic action":1,
"Nuclear receptor":1,
"Nasopharynx":1,
"Papillary adenocarcinoma":1,
"Squamous differentiation":1,
"Squamous metaplasia":1,
"Thyroid transcription factor-1 (TTF-1)":1,
"p40 (ΔNp63)":1,
"laser ablation":1,
"minimally invasive treatments":1,
"percutaneous thermal ablation":1,
"Autoimmune thyroid disease":1,
"Harmonization":1,
"Immunoassay":1,
"Thyroglobulin autoantibodies":1,
"Upper reference limit":1,
"Latero-cervical lymph node metastases":1,
"Papillary thyroid cancer":4,
"Thyroid cancer metastases":1,
"Thyroid cancer outcome":1,
"acoustic radiation force impulse":1,
"sonography":1,
"strain elastography":1,
"virtual touch tissue imaging":1,
"virtual touch tissue quantification":1,
"outcomes":1,
"recurrence":3,
"arterial enhancement":1,
"dual-phase CT":1,
"four-dimensional computed tomography":1,
"percentage arterial enhancement":1,
"primary hyperparathyroidism":2,
"CEUS":2,
"Neuroendocrine tumors":2,
"Prediction of response":1,
"Somatostatin analogues":1,
"adults":1,
"individual iodine status":1,
"iodine":1,
"serum iodine":1,
"thyroid diseases":1,
"thyroid function":1,
"urinary iodine":1,
"incidental findings":2,
"technical report":1,
"radiofrequency":1,
"thermal ablation therapies":1,
"thyroid nodules":5,
"BRAF mutation":2,
"response to therapy":1,
"risk stratification":1,
"Non-functioning parathyroid carcinoma":1,
"RT-PCR":1,
"Immune escape":2,
"Immune microenvironment":1,
"Lymph node metastasis":1,
"accessory nerve injuries":1,
"head and neck neoplasms":2,
"musculoskeletal pain":1,
"neck":1,
"neck dissection":2,
"neuralgia":1,
"pain":1,
"upper extremity":1,
"Core needle biopsy":1,
"Fine needle aspiration":3,
"Follicular neoplasm":2,
"distant metastasis":1,
"metabolite":1,
"metabolomics":1,
"ACLY":1,
"Immunity":1,
"Metabolic enzymes":1,
"Metastasis":7,
"PDC":1,
"Retrospective study":1,
"Sensitive diagnosis":1,
"Water iodine":1,
"Antibody drug conjugated":1,
"Chemoradiotherapy":1,
"Clinical trials":1,
"Immunotherapy":2,
"Prophylactic cranial radiation":1,
"Rovalpituzumab tesirine":1,
"birth rates":1,
"marker":1,
"thyroglobulin":2,
"ethanol ablation":1,
"discordant cancer":2,
"familial cancer":2,
"familial risk":2,
"genetic association":2,
"California Cancer Registry":1,
"Middle Eastern immigrants":1,
"cancer risk":2,
"different generations":1,
"hurthle cell neoplasm":1,
"medullary thyroid carcinoma":2,
"oncocytic":1,
"Korea":1,
"early diagnosis":1,
"mortality":4,
"standard population":1,
"birth outcome":1,
"cancer survivor":1,
"pregnancy":1,
"PSMA":1,
"Well-differentiated":1,
"18F-fluorodeoxyglucose":1,
"Multiple primary cancers":1,
"Oral cancer":1,
"PET-CT":1,
"Synchronous":1,
"follicular variant papillary thyroid carcinoma":1,
"noninvasive follicular thyroid neoplasm with papillary-like nuclear feature":1,
"thyroid carcinoma":6,
"Asian Continental Ancestry Group":1,
"Filipino":1,
"Philippines":1,
"clinical decision making":1,
"female":1,
"health status disparities":1,
"Graves’ disease":1,
"adrenocortical carcinoma":1,
"endocrine neoplasms":1,
"immune checkpoint inhibitors":1,
"ovarian cancer":1,
"pancreatic adenocarcinoma":1,
"Aspiration cytology":1,
"Macrofollicular variant":1,
"Noninvasive follicular thyroid neoplasm with papillary-like nuclear features":1,
"Body mass index":1,
"Breast neoplasms":3,
"Estrogen receptors":1,
"Progesterone receptors":1,
"Waist/hip ratio":1,
"immune system":1,
"thyroid cancers":1,
"cytology":3,
"reporting system":1,
"Number of children":1,
"Parity":1,
"Thyroid cancer risk":1,
"Cervical soft tissue recurrence":1,
"Differentiated thyroid carcinoma":4,
"GHRH antagonists":1,
"Growth hormone-releasing hormone":1,
"Hypothalamic hormone":1,
"mRNA for GHRH":1,
"mRNA for GHRH receptors":1,
"Cardiovascular diseases":1,
"Cataracts":1,
"Chernobyl":1,
"Leukemia":1,
"Multinational collaborations":1,
"Radiation":1,
"Thyroid disease":1,
"Dementia":1,
"Intellectual disability":1,
"Schizophrenia":1,
"Meta-analysis":2,
"Nonmedullary thyroid carcinoma":1,
"Review":2,
"diseases of the lacrimal system":1,
"drug-related side effects and adverse reactions":1,
"iodine radioisotopes":2,
"neoplasms of the thyroid gland/radiotherapy":1,
"radiation effects":2,
"RET oncogene":1,
"genetic variants":1,
"medullary thyroid cancer (MTC)":1,
"multiple endocrine neoplasia type 2 (MEN2)":1,
"pheochromocytoma (PHEO)":1,
"Thyroid Imaging Reporting and Data System":1,
"fine-needle aspiration":4,
"Medullary Thyrpod cancer":1,
"SSTR":1,
"Somatostatin":1,
"diagnosis":4,
"fine needle":1,
"thyroid aspirate":1,
"COPZ1":1,
"Cell death":1,
"Non-oncogene addiction":1,
"thyrotropin":2,
"thyroxine":2,
"triiodothyronine":1,
"ANRIL":1,
"Long non-coding RNA":1,
"Triple-negative breast cancer":1,
"miR-199a":1,
"Anaplastic thyroid cancer":3,
"Irinotecan":1,
"Sunitinib":1,
"Synergism":1,
"Tumor xenografts":1,
"Papillary thyroid cancer (PTC)":1,
"TRIM44":1,
"Wnt/β-catenin pathway":1,
"ligand binding assay":1,
"molecular docking":1,
"pesticides":1,
"surface plasmon resonance":1,
"thyroid receptor":1,
"Cellular biology":1,
"Molecular pathology":1,
"TERT":1,
"drug-resistance":1,
"lenvatinib":1,
"rechallenge":1,
"tyrosine-kinase inhibitors":1,
"BABA endoscopic thyroidectomy":1,
"Bilateral axillo-breast approach":1,
"Hyperfractionated accelerated radiotherapy":1,
"Thyroid surgery":2,
"Aggressive variant":1,
"Epithelial-mesenchymal transition":1,
"Hobnail":1,
"C611Y":1,
"Cys611Tyr":1,
"Denmark":1,
"REarranged during Transfection (RET)":1,
"founder effect":1,
"multiple endocrine neoplasia 2A (MEN2A)":1,
"consensus":1,
"inter-observer variability":1,
"pathologic reporting":1,
"tall-cell variant":1,
"clinical practice":1,
"differentiated thyroid cancer":3,
"evidence-based guidelines":1,
"radioiodine remnant ablation":1,
"anatomic variant":1,
"arteria lusoria":1,
"intrathyroidal carotid artery":1,
"nonrecurring recurrent laryngeal nerve":1,
"Enigma":1,
"bone morphogenetic protein-1 (BMP-1)":1,
"calcification":1,
"American Joint Committee on Cancer":1,
"American thyroid association":1,
"gastric cancer":1,
"glucose metabolism-related enzyme":1,
"glutaminase":1,
"molecular target":1,
"pyruvate kinase isozymes M2":1,
"EGFR targeting":1,
"anaplastic thyroid carcinoma":2,
"gene therapy":1,
"radioiodine":2,
"sodium–iodide symporter (NIS)":1,
"Protein kinase C δ":1,
"Ubiquitin-proteasome system":1,
"Parathyroidectomy":2,
"Radiology":2,
"Synchronous thyroid pathology":1,
"Cellular proteins":1,
"Countermeasures":1,
"Disease impact":1,
"Graphical queries":1,
"Semantic knowledgebase":1,
"Space research":1,
"Calcitonin":3,
"Ectopic hormone secretion":1,
"Functioning tumor":1,
"Non-functioning tumor":1,
"Pancreatic neuroendocrine neoplasm":1,
"Adolescents":2,
"Cancer registry":1,
"Japan":1,
"Young adults":1,
"FOXO3a":1,
"HCC":1,
"TRIP6":1,
"cytological features":1,
"poorly differentiated thyroid carcinoma":1,
"TERT promoter mutations":1,
"indeterminate cytology":2,
"molecular testing":1,
"thyroid liquid-based fine needle aspiration":1,
"Asia":1,
"borderline tumour":1,
"resection rate":1,
"risk of malignancy":2,
"thyroid FNAC":1,
"RET":2,
"Rb pathway":1,
"Childhood cancer":1,
"Paediatric oncology centre":1,
"Site of primary treatment":1,
"thyroid TIRADS":1,
"thyroid guidelines":1,
"Caveolin-1":1,
"PDAC":1,
"PTEN":2,
"lobectomy":1,
"total thyroidectomy":1,
"Area-level Deprivation":1,
"Hazard Ratio":1,
"Risk Factors":2,
"Survival Time":1,
"131I":1,
"outpatient":1,
"radiation safety":1,
"cancer survivors":1,
"diastolic dysfunction":1,
"late effects":1,
"pediatric patients":1,
"human bone marrow endothelial cell marker-1":1,
"ultrasonic examination":1,
"biological tumor markers":1,
"gene expression classifier":1,
"indeterminate thyroid nodules":1,
"non-invasive follicular thyroid neoplasm with papillary-like nuclear features":1,
"thyroid ultrasound":1,
"molecular":1,
"neoplasms":2,
"pathology":1,
"MTOR protein, human":1,
"Neoplastic stem cells":1,
"Phosphatidylinositol 3-kinases":1,
"Thyroid cancer, papillary":1,
"Thyroid carcinoma, anaplastic":1,
"Carcinome papillaire":1,
"Metastases":1,
"Métastase":1,
"Papillary carcinoma":1,
"Struma ovarii":1,
"Thyroïde":1,
"Curva de aprendizaje":1,
"FNAB":1,
"Fine needle aspiration biopsy":1,
"Learning curve":1,
"PAAF":1,
"Punción aspiración con aguja fina":1,
"Tiroides":1,
"Disease-free survival":1,
"HER2-negative breast cancer":1,
"Neoadjuvant chemotherapy":1,
"Zoledronic acid":1,
"Abdominal trauma":1,
"ERCP-related perforation":1,
"Horizontal duodenal perforation":1,
"EGb":1,
"Gene expression":1,
"Mapk":1,
"donor−acceptor chromophore":1,
"epidermal growth factor receptor":1,
"near-infrared window II":1,
"photoacoustic imaging":1,
"LC MS/MS":1,
"RIA":1,
"Thyroglobulin antibody":1,
"Microscopic extrathyroidal extension":1,
"Pathologic factor":1,
"Thyroid lobectomy":1,
"RhoA":1,
"p21cip":1,
"p27kip":1,
"simvastatin":1,
"NKX2–1":1,
"NSCLC":1,
"TP53":1,
"miR-33a":1,
"miR-365":1,
"microRNA":1,
"CEA":1,
"Primary unknown origin":1,
"Soft tissue metastasis":1,
"TTF-1":2,
"Renal cell carcinoma":2,
"glandular metastasis":1,
"kidney":1,
"thyroid gland":2,
"Indonesia":1,
"Talaromyces marneffei":1,
"lung":1,
"talaromycosis":1,
"AMPK signaling":1,
"Anti-tumor agents":1,
"Autophagy":1,
"Salidroside":1,
"cell proliferation":2,
"cyclin D1":1,
"papillary thyroid carcinoma cell":1,
"thyroid stimulating hormone":1,
"fibronectin 1":1,
"microRNA-139":1,
"progression":1,
"ERK2":1,
"Snail1":1,
"discoidin domain receptor 2":1,
"epithelial mesenchymal transition":1,
"Early detection of cancer":1,
"Second primary":1,
"Survivors":1,
"mouse models":1,
"nuclear medicine":1,
"preclinical imaging":1,
"theranostic":1,
"galectins":1,
"head and neck cancer":2,
"Double water-clear cell adenoma":1,
"hypercalcemic crisis":1,
"hyperparathyroidism":1,
"Endoscopy":1,
"Lymph node dissection":1,
"Papillary neoplasms":1,
"Treatment":2,
"Glycolysis":1,
"Growth":1,
"HSP90":1,
"Hepatocellular carcinoma":2,
"Active surveillance":1,
"Levothyroxine-posology":1,
"Macro-thyrotropin":1,
"Polyethylene glycol-precipitable thyrotropin":1,
"Bethesda":1,
"Encapsulated follicular variant of papillary thyroid carcinoma (EFVPTC)":1,
"Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":1,
"CXC chemokine":1,
"Chemokines":1,
"Integrin alpha Ⅴ beta3":1,
"CDI/PDI":1,
"Microvascular":1,
"Microvessel density":1,
"Superb microvascular imaging":1,
"Carcinoembryonic antigen (CEA)":1,
"Fluorodeoxyglucose-positron emission tomography (FDG-PET)":1,
"Medullary thyroid cancer":3,
"NRCRM":2,
"Chornobyl":1,
"epidemiology":1,
"internation al cooperation":1,
"personnel":1,
"radiation hygiene":1,
"treatment of victims":1,
"Vitamin D":1,
"etiology":1,
"Endocrinology":1,
"Healthy control":1,
"Procalcitonin":1,
"Public health":1,
"Thyroid nodes":1,
"Oral vestibule":1,
"mental nerve":1,
"Papillary thyroid microcarcinoma":1,
"central lymph node metastasis":1,
"Cyclooxygenase-2":1,
"gene polymorphism":1,
"EGFRvIII":1,
"HNSCC":1,
"chemo-sensitivity":1,
"β-catenin":1,
"insulin receptor substrate 1":1,
"long noncoding RNA H19":1,
"RAS inhibitors":1,
"RET inhibitors":1,
"bioinformatics":1,
"biomarker":3,
"dysregulation network":1,
"differentially expressed mRNA":1,
"differentially expressed miRNAs":1,
"follicular thyroid tumors":1,
"gene ontology enrichment analysis":1,
"network analysis":1,
"endocrine cancer":1,
"parathyroid carcinoma":1,
"radical resection":1,
"all-trans-retinoic acid":1,
"isotope susceptibility":1,
"sodium/iodine symporter":1,
"Deep vein thrombosis":1,
"Pulmonary embolus":1,
"Venous thromboembolism":1,
"PROX1":1,
"cytoskeleton":1,
"follicular thyroid carcinoma":1,
"CXCL10":1,
"CXCR3":1,
"chemokine receptors":1,
"inflammation":1,
"RGD peptide":1,
"TENIS syndrome":1,
"integrin αvβ3":1,
"thymus":1,
"Gas5":1,
"competing endogenous RNA":1,
"Diagnostic oncology":1,
"FNAC and histology":1,
"Clear cell oncocytoma":1,
"Parotid":1,
"STAT3":1,
"antiangiogenics":1,
"iung toxicity":1,
"radioembolization":1,
"Adenocarcinoma":1,
"Esophageal":1,
"Metastatic":1,
"Dermatofibrosarcoma protuberans":1,
"Hamartoma syndrome":1,
"malignant progression mRNA":1,
"miRNA":1,
"thyroid follicular adenoma":1,
"thyroid follicular carcinoma":1,
"renal transplantation":1,
"Needle Biopsy":1,
"Thyroid Cytology":1,
"chylous leakage":1,
"thoracoscopes":1,
"arteries":1,
"tracheotomy":1,
"veins":1,
"MIVAP":1,
"MIBI":1,
"Chemotherapy":1,
"Non-small cell lung cancer":1,
"Pemetrexed":1,
"Thyroid transcription factor-1":1,
"developmental therapeutics":1,
"sorafenib":1,
"tolerability study":1,
"Electron microscope":1,
"Gangliocytoma":1,
"Mixed gangliocytoma-pituitary adenoma":1,
"Pituitary adenoma":1,
"Sellar tumor":1,
"Surgical resection":1,
"CO2 Laser":1,
"Laryngo-Microsurgery":1,
"Larynx":1,
"Saccular Cyst":1,
"Saccule":1,
"Microvascular thyroid transplant":1,
"Radiation induced hypothyroidism":1,
"DPF3":1,
"SWI/SNF complex":1,
"MiR-381":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2017年12月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
